Table of Contents
<< Previous Issue | Apr 2010 (Vol: 2010, Issue: 4) | Next Issue >> |
- Section: Licensing
-
Takeda Sets Eyes to Globally Market AMAG’s Anemia Drug
-
Mersana and Teva in USD 334 M deal for preclinical cancer drug
-
Isis Pharmaceuticals Bags USD 35 M Up Front in Deal with GSK
-
Celgene and Agios Form a Global Strategic Collaboration to Target Cancer Metabolism
- Section: Mergers & Acquisitions
-
MDRNA on Overdrive
- Section: Research & Development
-
Pfizer Steps Up Asia-Specific Drug Discovery for Tuberculosis